Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.

Arnold LE, Aman MG, Li X, Butter E, Humphries K, Scahill L, Lecavalier L, McDougle CJ, Swiezy NB, Handen B, Wilson K, Stigler KA.

J Am Acad Child Adolesc Psychiatry. 2012 Nov;51(11):1173-84. doi: 10.1016/j.jaac.2012.08.028. Epub 2012 Oct 9.

2.

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial.

Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, Kohn AE, Koenig K, Hollway JA, Korzekwa P, Gavaletz A, Mulick JA, Hall KL, Dziura J, Ritz L, Trollinger S, Yu S, Vitiello B, Wagner A; Research Units on Pediatric Psychopharmacology Autism Network.

J Am Acad Child Adolesc Psychiatry. 2009 Dec;48(12):1143-54. doi: 10.1097/CHI.0b013e3181bfd669. Erratum in: J Am Acad Child Adolesc Psychiatry. 2010 Jul;49(7):727.

3.

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, Hollway JA, Korzekwa P, Gavaletz A, Kohn AE, Koenig K, Grinnon S, Mulick JA, Yu S, Vitiello B; Research Units on Pediatric Psychopharmacology Autism Network.

J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):136-46. doi: 10.1016/j.jaac.2011.11.010. Epub 2011 Dec 23.

4.

Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.

Farmer C, Lecavalier L, Yu S, Eugene Arnold L, McDougle CJ, Scahill L, Handen B, Johnson CR, Stigler KA, Bearss K, Swiezy NB, Aman MG.

J Autism Dev Disord. 2012 Jun;42(6):1037-44. doi: 10.1007/s10803-011-1338-2.

5.

Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial.

Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, McAdam DB, Butter E, Stillitano C, Minshawi N, Sukhodolsky DG, Mruzek DW, Turner K, Neal T, Hallett V, Mulick JA, Green B, Handen B, Deng Y, Dziura J, Scahill L.

JAMA. 2015 Apr 21;313(15):1524-33. doi: 10.1001/jama.2015.3150. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.

PMID:
25898050
6.

Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.

Ishitobi M, Kosaka H, Takahashi T, Yatuga C, Asano M, Tanaka Y, Ueno K, Okazaki R, Omori M, Hiratani M, Tomoda A, Wada Y.

Clin Neuropharmacol. 2013 Sep-Oct;36(5):151-6. doi: 10.1097/WNF.0b013e3182a31ec0.

PMID:
24045605
7.

Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.

Scahill L, Aman MG, McDougle CJ, Arnold LE, McCracken JT, Handen B, Johnson C, Dziura J, Butter E, Sukhodolsky D, Swiezy N, Mulick J, Stigler K, Bearss K, Ritz L, Wagner A, Vitiello B.

J Autism Dev Disord. 2009 May;39(5):720-9. doi: 10.1007/s10803-008-0675-2. Epub 2008 Dec 19.

8.

A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.

Findling RL, Mankoski R, Timko K, Lears K, McCartney T, McQuade RD, Eudicone JM, Amatniek J, Marcus RN, Sheehan JJ.

J Clin Psychiatry. 2014 Jan;75(1):22-30. doi: 10.4088/JCP.13m08500.

PMID:
24502859
9.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005.

10.
11.

A systematic review of medical treatments for children with autism spectrum disorders.

McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J.

Pediatrics. 2011 May;127(5):e1312-21. doi: 10.1542/peds.2011-0427. Epub 2011 Apr 4. Review.

PMID:
21464191
12.

Aripiprazole for autism spectrum disorders (ASD).

Hirsch LE, Pringsheim T.

Cochrane Database Syst Rev. 2016 Jun 26;(6):CD009043. doi: 10.1002/14651858.CD009043.pub3. Review.

PMID:
27344135
13.

Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.

Scahill L, Hallett V, Aman MG, McDougle CJ, Eugene Arnold L, McCracken JT, Tierney E, Deng Y, Dziura J, Vitiello B; Research Units on Pediatric Psychopharmacology (RUPP) Autism Network).

J Autism Dev Disord. 2013 Mar;43(3):739-46. doi: 10.1007/s10803-012-1689-3.

14.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
15.

Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world.

Ameis SH, Corbett-Dick P, Cole L, Correll CU.

J Clin Psychiatry. 2013 Oct;74(10):1022-4. doi: 10.4088/JCP.13ac08691. No abstract available.

PMID:
24229756
16.

Aripiprazole for autism spectrum disorders (ASD).

Ching H, Pringsheim T.

Cochrane Database Syst Rev. 2012 May 16;(5):CD009043. doi: 10.1002/14651858.CD009043.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD009043.

PMID:
22592735
17.
18.

Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.

Lynch TR, Cheavens JS, Cukrowicz KC, Thorp SR, Bronner L, Beyer J.

Int J Geriatr Psychiatry. 2007 Feb;22(2):131-43.

PMID:
17096462
19.

Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.

Valicenti-McDermott MR, Demb H.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):549-60.

PMID:
17069544
20.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353

Supplemental Content

Support Center